يحاول ذهب - حر
'In HP-TLC, Each And Every Parameter That Influences The Result Is Controlled'
April 16, 2018
|Express Pharma
-
What is the background of Anchrom?
My father Dilip Charegaonkar is India’s first full fledged R&D Analyst who worked in Themis Pharmaceuticals from 1976. In 1978, he quit to promote TLC when HPLC started coming in. To this day TLC, instrumental TLC (I-TLC) and High Performance Thin Layer Chromatography (HPTLC) are irreplaceable, partly because of Anchrom’s dedicated effort. Since the last nine years, me and later my wife have actively joined him, at Anchrom. This year, is the 40th year of our association with Camag, Switzerland who pioneered HP-TLC.
What is unique about HP-TLC?The sample is literally ‘visible’ throughout. Chromatography is done in independent steps. No high temperature or pressure is involved and is fastest of all chromatography methods. Samples do not come into contact with the chromatograph. Chromatogram retained on plate. Hence, multiple modes of detection can be applied. Samples can be cleaned up on the (disposable) plate.
I-TLC. Is it a new concept?
Instrumental TLC (I-TLC) is halfway between manual TLC and regulatory level HPTLC. I-TLC has all the advantages of instrumentation but the chromatography methodology is not standardised.
Will HP-TLC replace ITLC?
HP-TLC is I-TLC + methodology, so it’s not a replacement but an improvement. In HP-TLC, each and every parameter that influences the result is controlled. However, labs in developing countries will use TLC, I-TLC as well as HPTLC for economic reasons.
Do you have an application lab?
هذه القصة من طبعة April 16, 2018 من Express Pharma.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Express Pharma
Express Pharma
Speed and flexibility play a critical role in how we compete with larger global players
Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma
6 mins
January 2026
Express Pharma
Vizag rising: Shaping India's pharma future
At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth
9 mins
January 2026
Express Pharma
Future of pharma: Trends, challenges & AI
Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies
2 mins
January 2026
Express Pharma
Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments
When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.
1 mins
January 2026
Express Pharma
Can Indian biosimilars and generics restate accessibility in global underserved markets?
Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare
3 mins
January 2026
Express Pharma
The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers
As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.
6 mins
January 2026
Express Pharma
Results win customers. Leadership discipline keeps them
Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.
3 mins
January 2026
Express Pharma
INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF
India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge
8 mins
January 2026
Express Pharma
PRUV® -The original Sodium Stearyl Fumarate
JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago
5 mins
January 2026
Express Pharma
Odisha's pharma pitch
The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury
5 mins
January 2026
Translate
Change font size
